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THE RISK OF DEVELOPING TYPE 1 DIABETES IS INCREASED BY CERTAIN VARIANTS OF THE HLA GENES

Amira Djama, Southern Maine Community College, South Portland Maine04106

ABSTRACT
Type 1 diabetes mellitus is an autoimmune disorder that occurs due
to a deficiency in insulin that occurs because of damage to insulin-producing
pancreatic beta cells. Genetics plays a vital role in the progression of this
disease. The etiology of this disease includes a genetic predisposition if there are
particular alleles within the HLA class II region, a part of the human genome
that encodes cell-surface proteins that regulate the immune system. This
literature review looks at research suggesting that 40 or more loci confer a
predisposition to type 1 diabetes. Changes in the genes that are present in the
HLA region on chromosome 6 have been shown to confer greater risk of this
type of diabetes. The genes that are strongly linked with this disease are HLADR, DQ and DP. However, there is also a non-HLA region that has a
contribution to development of risk stratification. A combination of multiple
genes was found to have an impact on the occurrence of type 1
diabetes, especially among children. Currently, there is no cure for the disease
and patients require life-long insulin injections that help in the management of
their diabetes. Genetics do not yet have an association with the management and
prevention of the illness, but research is being conducted in order to design
interventions targeting the genetic factors that may one day give the option of a
complete cure.
INTRODUCTION
q Type 1 diabetes is a chronic health condition in which the pancreas
produces insufficient or no insulin.
q It is the one of the most researched genetic disorder and there are
reported that there is a 40% to 50% of the familial aggregation of
type 1 diabetes with HLA genes.
q The genetic determinant of the disease is the mutation or
polymorphism in class II HLA genes that are responsible for coding
DQ and DR.
q Therefore, it can be stated that there is a strong correlation between
the risk of developing type 1 diabetes and HLA genes.
Antigen processing and presentation is the process
by which protein antigen is absorbed by an antigenpresenting cell (APC), partly breaks down into
peptide fragments and then present on the surface
of the APC associated with an antigen-presenting
molecule MHC class II, for acknowledgment by
certain lymphocytes such as T cells.
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This figure shows a genome-wide association(GWA)
study that has speeded up studies related to the causes
of type 1 diabetes. the best estimate of the odds risk
alleles is shown a large number of loci. There are the
genomic region where convincing association with the
disorder have been found.

This figure shows the HLA region on
chromosome number 6 and it can be
observed that the type 1 diabetes is
associated with haplotypes that include
DRB*03-DQB1*02 and DRB1*04DQB1*0302.

CONCLUSION
Type I diabetes is stated to be one of most commonly studied and complex
genetic disease that has an association with the gene in the HLA that accounts
for 40% to 50% of the familial aggregation in the illness. It was found that the
genetic determinants of the disorder involve the polymorphisms of class
II HLA genes that are responsible for coding DQ and DR. The use
of GWAS and genome extensive linkage analysis have been recently used
where it was found that HLA gene complex, as well as non-HLA genes
including INS, PTPN22 and CTLA-4, are in conjunction with the
development and progress of Type I diabetes. Ten genetic markers have been
identified in the study that would help in general population screening where
typing was done with two or more SNPs from the HLA regions and
Insulin is produced in the islet of Langerhans
nine SNPs from other genes. The use of insulin minisatellite (INS VNTR) are
in the pancreas. The islets contain beta cells associated with susceptibility of a number of disorders due to its association
and blood vessel. In some condition where
with a wide range of phenotypes. Thus, it can be stated that the association of
the beta cells are destroyed and thus, causes type I diabetes and HLA genes required in-depth studies that may help in
type 1 diabetes.
disease understanding and development of a cure for the life-threatening
disease.
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